EVIDENCE COMPARISON

Directional

Ivermectin
vs Oxytetracycline
for Redness Reduction

Early or indirect evidence suggests ivermectin reduces redness more effectively than oxytetracycline, supporting better skin tone outcomes, based on indirect comparison.

1.40x

Effect ratio

Ivermectin

Favored

2

Studies

Indirect

Comparison

ExploratorySubjective endpointTone

Limits: Includes subjective endpoint · Indirect comparison · Abstract-only source · Estimated effect size · Directional evidence tier

This is an indirect comparison — the two ingredients were not tested head-to-head in the same trial. The ratio is derived from separate studies against a common comparator.

How to read this claim

Published as an exploratory public claim: direct comparison with exact provenance, but with limits noted for includes subjective endpoint, indirect comparison, abstract-only source, estimated effect size, directional evidence tier.

The underlying trial context suggests this comparison may not generalize cleanly beyond the specific tested formulations.

Upstream study enrichment was not enabled for this export, so formulation-specific trial context may be incomplete here.

Source Studies (2)

Dermoscopic Response Predictors in Papulopustular Rosacea Treated with Topical Ivermectin and Metronidazole: A Prospective Observational Comparative Study.

randomized

A double-blind study of I% metronidazole cream versus systemic oxytetracycline therapy for rosacea.

controlled
Explore all comparisons →